Investing.com - Alpine Immune Sciences (NASDAQ: ALPN) reported first quarter EPS of $-0.280, $0.14 better than the analyst estimate of $-0.420. Revenue for the quarter came in at $7.03M versus the consensus estimate of $3.52M.
Alpine Immune Sciences's stock price closed at $64.82. It is up 123.210% in the last 3 months and up 723.630% in the last 12 months.
Alpine Immune Sciences saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Alpine Immune Sciences's stock price’s past reactions to earnings here.
According to InvestingPro, Alpine Immune Sciences's Financial Health score is "good performance".
Check out Alpine Immune Sciences's recent earnings performance, and Alpine Immune Sciences's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar